Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Gynecol Oncol. 2009 Jan 21;113(1):21–27. doi: 10.1016/j.ygyno.2008.12.003

Table 4.

Tumor response and acneiform rash severity by maximum dose

Dose Number of patients Responses at each dose and grade
22a
250 mg/m2 rash
Grade 0,1 8 1SDb, 7PDc
Grade 2 5 2 SD, 3PD
Grade 3 1 1PD
325 mg/m2 rash
Grade 0,1 1 1SD
Grade 2 3 2SD, 1UDd
Grade 3 0
400 mg/m2 rash
Grade 0,1 1 1SD
Grade 2 2 2SD
Grade 3 1 1PRe
a

3 patients received only the loading dose (1 due to rapid progression; 1 due to severe hypersensitivity reaction; 1 due to reclassification of original histology.

b

SD = stable disease.

c

PD = progressive disease.

d

UD = undeterminable.

e

PR = partial remission.